Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease. (Q48484232)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 August 2011
edit
Language Label Description Also known as
English
Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease.
scientific article published on 26 August 2011

    Statements

    Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit